Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 32
  • 1
  • 2
  • »
The Ohio State University Comprehensive Cancer Center developed the James Cancer Diagnostic Center, to deliver a comprehensive assessment of signs or symptoms of malignancy in a timely fashion.
ACCC conducted a comprehensive survey and a series of four focus groups to explore current attitudes, beliefs, and concerns related to multi-cancer early detection.
Cancer and its treatment impact patients in many ways, beginning before a diagnosis and lasting long through survivorship, including one's sexual health. All of Me was created to bridge this communication gap between patients and providers.
With an aging U.S. population and a projected shortage of medical oncologists, oncology pharmacists and the critical support they provide in the management of patient symptoms and comorbidities is more important than ever.
The Iowa Oncology Society launched an educational project designed to spark conversations, and raise awareness about the importance of genetic testing, counseling, and screening.
Disparities in evaluation, management, and mortality persist in patient populations where bladder cancer is less common.
The COVID-19 pandemic has had a negative impact in the rate of cancer screening across various states in the United States. Louisiana, Delaware, Kentucky and Northern Michigan serve as vehicles for an analysis of the disparity in cancer screening rates, before and after the pandemic.
The overall cancer rate among adolescents and young adults is on a gradual increase, thus creating the need for oncology programs geared towards young adults and adolescents.
A mix-method approach to understand clinician use of biomarker testing for patients with non-small cell lung cancer.
In 2021, ACCC held a series of focus groups to learn how cancer programs are effectively implementing telehealth to manage symptoms and treatment side effects, deliver psychosocial screening and support services, and provide genetic counseling and testing.
As precision medicine becomes more common in the management of lung cancer, little is understood about the patient experience with biomarker testing, particularly of underserved patients. This study used survey and focus group methodology to determine patient perspectives on the educational needs within this community.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
An integrated precision tracking program ensures proper follow-up care and surveillance for survivors of colorectal cancer.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
St. Vincent Hospital implemented a collaborative method of care that uses genetic counselor extenders to increase patient access to risk assessment and genetic testing.
Early identification, staging, and diagnosis of lung cancer is critical to improving patient outcomes. However, current diagnostic options are limited in accuracy, safety, and invasiveness—only 15 percent of patients with lung cancer are diagnosed at an early stage. Read how Fox Chase Cancer Center has implemented new flexible robotic endoscopic technology to diagnose hard-to-reach lung nodules with …
Because of its growing retirement-age population and its unique location on a barrier island, The Outer Banks Hospital saw patients with lung cancer presenting at too late a stage for curative treatment. Learn how the hospital created an LDCT program and partnered with local providers and community cancer centers to identify patients with lung cancer at an earlier stage.
Lung cancer screenings are more effective and more affordable than ever before, but patient access still poses significant hurdles. Read how Levine Cancer Institute’s mobile lung LDCT unit brings lung screenings to underserved communities.
The Inherited Cancer Registry (ICARE) is an academic-community partnership among healthcare providers, researchers, and individuals at an increased risk for inherited cancer. Learn about ICARE’s research registry for high-risk individuals and education efforts on inherited cancer for both patients and providers.
ASCO 2018 offered a wealth of new data that will continue to transform clinical practice and cancer program development. Most important, implementation of the scientifi c advances we learned at ASCO 2018 will improve the length and quality of life of our cancer patients.
    Displaying results 1 - 20 of 32
  • 1
  • 2
  • »